Crohn’s Disease and Ulcerative Colitis: Pathophysiology and New Therapeutic Strategies

Dear Colleagues,

This Special Issue concerns the recent therapeutic developments in the management of Crohn's Disease and Ulcerative Colitis. There will be a focus on the role of the intestinal microbiome in the development of Crohn's Disease and Ulcerative Colitis, and the therapeutic place of new probiotics in the management of these conditions. The Special Issue also reflects on the place of newer biologic therapies and JAK inhibitors in the control of inflammatory process. Stem cell therapy and other new drugs targeting the inflammatory process will also be reviewed. All studies and reviews relating to the mechanisms and therapeutic strategies of Crohn's Disease are welcome.

You may choose our Joint Special Issue in Biomedicines.

Dr. Affifa Farrukh
Prof. Dr. John Mayberry
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• microbiome
• probiotics
• biologics
• JAK inhibitors
• stem cell therapy
• new molecules